2itz: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
caption="2itz, resolution 2.80Å" />
caption="2itz, resolution 2.80Å" />
'''CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA'''<br />
'''CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA'''<br />
==Disease==
Known diseases associated with this structure: Adenocarcinoma of lung, response to tyrosine kinase inhibitor in OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=131550 131550]], Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=131550 131550]], Nonsmall cell lung cancer, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=131550 131550]]


==About this Structure==
==About this Structure==
Line 39: Line 42:
[[Category: zd1839]]
[[Category: zd1839]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 18:16:36 2007''
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:48:04 2007''

Revision as of 23:41, 12 November 2007

File:2itz.gif


2itz, resolution 2.80Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA

DiseaseDisease

Known diseases associated with this structure: Adenocarcinoma of lung, response to tyrosine kinase inhibitor in OMIM:[131550], Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in OMIM:[131550], Nonsmall cell lung cancer, susceptibility to OMIM:[131550]

About this StructureAbout this Structure

2ITZ is a Single protein structure of sequence from Homo sapiens with CL and IRE as ligands. Active as Receptor protein-tyrosine kinase, with EC number 2.7.10.1 Structure known Active Site: AC2. Full crystallographic information is available from OCA.

Page seeded by OCA on Mon Nov 12 22:48:04 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA